BioCentury
ARTICLE | Company News

Theratechnologies other research news

April 29, 2002 7:00 AM UTC

Researchers published in Blood that PDT can selectively deplete host alloantigen-specific T cells to prevent GvHD, while preserving immune and anti-leukemia functions. In a mouse model of leukemia, an...